login
login

Europe Daily Bulletin No. 12520

4 July 2020
Contents Publication in full By article 19 / 36
EU RESPONSE TO COVID-19 / Health
Green light for conditional approval of antiviral drug Remdesivir in EU

03/07/2020 (Agence Europe)The European Commission authorised on Friday 3 July the conditional approval of the antiviral drug Remdesivir (see EUROPE B12519A2). This drug is the first one authorised in the European Union to treat Covid-19. Experts believe it is effective and has few side effects, although further testing during treatments is still needed. Permitted through a fast-track procedure, this conditional authorisation comes only one week after a positive recommendation from the...

Contents

ECONOMY - FINANCE - BUSINESS
SECTORAL POLICIES
INSTITUTIONAL
EU RESPONSE TO COVID-19
SECURITY - DEFENCE
EXTERNAL ACTION
SOCIAL AFFAIRS
NEWS BRIEFS
CALENDAR
CALENDAR EXTRA